Skip to main content
NCBI home page
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 1976 Jul;73(7):2280–2284. doi: 10.1073/pnas.73.7.2280

Antibody evidence for different conformational states of ADP, ATP translocator protein isolated from mitochondria.

B B Buchanan, W Eiermann, P Riccio, H Aquila, M Klingenberg
PMCID: PMC430529  PMID: 1065877

Abstract

Consistent with the previously proposed reorientation mechanism for the ADP,ATP translocator protein of mitochondria, evidence has now been obtained for the existence of two distinct conformational states of the isolated translocator protein. Previous studies indicated that when the mitochondrial translocator protein is in the c-state(i.e., when its binding site faces the cytosol side) the protein binds primarily the ligand carboxyatractylate (CAT), and when the translocator protein is in the m-state(i.e., when its binding site faces the mitochondrial matrix) the translocator protein binds primarily bongkrekate. Direct evidence for this formulation has now come from the application of antibodies to the isolated translocator protein-ligand complex. Two antibodies were produced against the ADP,ATP translocator protein isolated from beef heart mitochondria. One antibody, which was produced against the protein isolated as the CAT-binding protein complex, was found to be highly specific for that complex and did not react with the protein in the conformation state conferred by the bongkrekate ligand. This antibody did not cover the CAT-binding site, as evidenced by the exchange of unlabeled CAT with [35S]CAT bound to the translocator protein. However, the same antibody inhibited a transition of the protein from the c-state to the m-state, as evidenced by an inhibition of the displacement of[35S]CAT by bongkrekate (added jointly with ADP). It appears, therefore, that the antibody immobilized the translocator protein in the c-state. The second antibody produced against the (somewhat less pure) ADP,ATP translocator protein, isolated as the bongkrekate-binding protein complex, did not react with the CAT-binding protein. Thus, the second antibody appeared to be specific for the translocator protein in the m-state. Neither antibody inhibited mitochondrial ADP,ATP transport.

Full text

PDF
2280

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Erdelt H., Weidemann M. J., Buchholz M., Klingenberg M. Some principle effects of bongkrekic acid on the binding of adenine nucleotides to mitochondrial membranes. Eur J Biochem. 1972 Oct 17;30(1):107–122. doi: 10.1111/j.1432-1033.1972.tb02077.x. [DOI] [PubMed] [Google Scholar]
  2. Klingenberg M., Buchholz M. On the mechanism of bongkrekate effect on the mitochondrial adenine-nucleotide carrier as studied through the binding of ADP. Eur J Biochem. 1973 Oct 5;38(2):346–358. doi: 10.1111/j.1432-1033.1973.tb03067.x. [DOI] [PubMed] [Google Scholar]
  3. Lauf P. K. Antigen-antibody reactions and cation transport in biomembranes: immunophysiological aspects. Biochim Biophys Acta. 1975 Jun 30;415(2):173–229. doi: 10.1016/0304-4157(75)90002-7. [DOI] [PubMed] [Google Scholar]
  4. Leblanc P., Caluser H. ADP-dependent inhibition of sarcosomal adenine nucleotide translocase by N-ethylmaleimide. FEBS Lett. 1972 Jun 1;23(1):107–113. doi: 10.1016/0014-5793(72)80296-5. [DOI] [PubMed] [Google Scholar]
  5. Masters B. S., Baron J., Taylor W. E., Isaacson E. L., LoSpalluto J. Immunochemical studies on electron transport chains involving cytochrome P-450. I. Effects of antibodies to pig liver microsomal reduced triphosphopyridine nucleotide-cytochrome c reductase and the non-heme iron protein from bovine adrenocortical mitochondria. J Biol Chem. 1971 Jul 10;246(13):4143–4150. [PubMed] [Google Scholar]
  6. McCans J. L., Lane L. K., Lindenmayer G. E., Butler V. P., Jr, Schwartz A. Effects of an antibody to a highly purified Na+, K+-ATPase from canine renal medulla: separation of the "holoenzyme antibody" into catalytic and cardiac glycoside receptor-specific components. Proc Natl Acad Sci U S A. 1974 Jun;71(6):2449–2452. doi: 10.1073/pnas.71.6.2449. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Riccio P., Aquila H., Klingenberg M. Purification of the carboxy-atractylate binding protein from mitochondria. FEBS Lett. 1975 Aug 1;56(1):133–138. doi: 10.1016/0014-5793(75)80127-x. [DOI] [PubMed] [Google Scholar]
  8. Riccio P., Aquila H., Klingenberg M. Solubilization of the carboxy-atractylate binding protein from mitochondria. FEBS Lett. 1975 Aug 1;56(1):192–132. [PubMed] [Google Scholar]
  9. Scherer B., Klingenberg M. Demonstration of the relationship between the adenine nucleotide carrier and the structural changes of mitochondria as induced by adenosine 5'-diphosphate. Biochemistry. 1974 Jan 1;13(1):161–170. doi: 10.1021/bi00698a025. [DOI] [PubMed] [Google Scholar]
  10. Vignais P. V., Vignais P. M. Effect of SH reagents on atractyloside binding to mitochondria and ADP translocation. Potentiation by ADP and its prevention by uncoupler FCCP. FEBS Lett. 1972 Oct 1;26(1):27–31. doi: 10.1016/0014-5793(72)80534-9. [DOI] [PubMed] [Google Scholar]
  11. Werner S. Isolation and characterisation of a mitochondrially synthesized precursor protein of cytochrome oxidase. Eur J Biochem. 1974 Mar 15;43(1):39–48. doi: 10.1111/j.1432-1033.1974.tb03382.x. [DOI] [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES